Dieta-1200x674.jpg

Diet

The role of diet is crucial in the development and prevention of cardiovascular diseases (CVD). Diet is a key modifiable risk factor for CVD.

Change in eating habits

The average weight of humans is increasing. In the second half of the 20th century there were major changes in daily diets, from plant-based diets to high-fat animal-based diets.

The obesity epidemic is spreading to low- and middle-income countries as a result of new eating habits and sedentary lifestyles, which fuel chronic disease and premature mortality.

Components of a healthy diet

A healthy diet should be low in saturated fat, salt, and carbohydrates, and high in fruits and vegetables. Also, eating whole grains, at least two servings of fish a week, and nuts can reduce the risk of cardiovascular disease.

The World Health Organization (WHO) recommends that individuals:

Limit fat intake and shift fat intake from saturated fat to unsaturated fat and toward eliminating trans fat.

Increase consumption of fruits and vegetables, and whole grains and nuts. Adults should consume at least 500g of fresh fruits and vegetables per day.
Limit intake of free sugars and intake of salt (sodium) from all sources. A recent guideline recommends eating less than 1,500 mg of sodium a day

Overweight and obesity

Overweight and obesity are classified according to the individual’s body mass index (BMI). The BMI is measured by dividing a person’s weight by their height squared in meters. In adults, overweight is defined as a BMI of 25.0 to 29.9 kg/m2; obesity is defined as a BMI of 30.0 kg/m2 or higher.

Impact of Obesity on Heart Health

Obesity is an independent risk factor for cardiovascular disease. An overweight person can develop hypertension, type 2 diabetes, and musculoskeletal disorders.

Increased body weight leads to an increased risk of developing type 2 diabetes and the incidence of hypertension increases. Statistics show that 58% of diabetes mellitus worldwide and 21% of chronic heart disease are attributable to a BMI greater than 21%.

Excess fat can also affect a person’s blood pressure and blood lipid levels, interfering with their ability to use insulin effectively.


nota1-2-1200x800.jpeg

Cholesterol already has a vaccine, at least that’s what the latest edition of the European Heart Journal says. This is because researchers from the Medical University of Vienna managed to succeed in tests with laboratory mice.

The new vaccine is capable of reducing fatty deposits accumulated in the arteries that cause patients to take pills day after day to reduce the risk of heart attacks, as well as reducing the amount of bad cholesterol in the blood. According to experts, the vaccine will be ready in approximately six more years.


nota2-1200x800.jpeg

Scientists from the Hospital del Vall d’Hebron in Barcelona have demonstrated in a trial with rats the effectiveness of an oral treatment that reduces the consequences of myocardial infarction on heart function, even if the medication is administered one day after suffering the infarction .

The Cardiovascular Disease Research group of the Vall d’Hebron Research Institute (VHIR) led by David Gacía-Dorado has carried out this study with rats in which they have shown for the first time that the chronic inhibition of calpains (enzymes activated by the increase in intracellular calcium) is possible through an oral treatment that attenuates damage to the heart after an acute myocardial infarction.

It acts against the overactivation of calpains

The study, published in the journal Cardiovascular Research, used a transient coronary occlusion infarction model in rats to show that calpains remain overactivated during the weeks following an infarction and that this overactivation plays a fundamental role in the appearance of ventricular remodeling. adverse, a series of changes that affect the heart after the heart attack favoring the appearance of arrhythmias.

“Daily oral administration of a new calpain inhibitor -with properties that make it absorbable by the oral route- prevents this overactivation, reduces ventricular remodeling and improves contractile function 21 days after the infarction, even if treatment is started a little later. day after coronary occlusion”, summarized Dr. Javier Inserte, principal investigator of the VHIR Cardiovascular Diseases Research group.

The experienced treatment, according to Insert, decreases hypertrophy, fibrosis, and inflammation in the non-infarcted myocardium.

According to the researchers, the results suggest that this protective effect of calpain inhibition is due to the prevention of calpain’s effect on molecules that regulate gene expression.

“This study demonstrates for the first time that chronic calpain inhibition is possible by oral treatment and may represent a therapeutic strategy aimed at attenuating adverse remodeling and heart failure in patients surviving acute myocardial infarction,” he stressed. Garcia-Dorado.

Myocardial infarction, a condition generally caused by thrombotic occlusion of a coronary artery, is one of the main manifestations of ischemic heart disease.


nota3.jpeg

Xavi Pascual, former Barça basketball coach and current Panathinaikos coach, will not have to undergo heart surgery, although he will visit a specialist in Barcelona. Initially there was a scare after the Greek website Sport 24 reported a heart condition that required a bypass.

Pascual, 44, felt unwell last Sunday and was hospitalized in Athens. There he underwent various tests that detected a heart problem. Yesterday Tuesday he was discharged. In Barcelona, ​​the coach of the Greek champion will receive a second opinion to determine the extent of his ailment.

“I want to thank everyone for their interest in me. I have gone to the hospital to undergo some medical tests, but I am fine. I will continue with my plans and tomorrow I will travel to Barcelona for the Euroleague coaches meeting. Thank you all for taking an interest in me”, declared the Catalan coach after leaving the hospital.

Xavi Pascual began coaching the Greek team this 2016/17 season, in which he has won the league and the cup, after developing his career at Barça, between 2008 and 2016.



Location

Privada Ignacio Zaragoza PTE # 16 II A Col. Centro.
Querétaro, Qro.


Phone

(442) 216 2745 y 46
(442) 242 5068
(442) 242-64-35


FOLLOW US



Instituto de Corazón de Querétaro 2018.



Instituto de Corazón de Querétaro 2018.